Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors.
Shroff RT, Chalasani P, Wei R, Pennington D, Quirk G, Schoenle MV, Peyton KL, Uhrlaub JL, Ripperger TJ, Jergović M, Dalgai S, Wolf A, Whitmer R, Hammad H, Carrier A, Scott AJ, Nikolich-Žugich J, Worobey M, Sprissler R, Dake M, LaFleur BJ, Bhattacharya D.
Shroff RT, et al. Among authors: sprissler r.
Nat Med. 2021 Nov;27(11):2002-2011. doi: 10.1038/s41591-021-01542-z. Epub 2021 Sep 30.
Nat Med. 2021.
PMID: 34594036
Free PMC article.
Clinical Trial.